From choice, a world of possibilities
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Almost 30 countries vulnerable to a new Ebola-style Epidemic, jeopardising the future of millions of Children. The report ranks the world’s poorest countries on the state of their public health systems, finding that 28 have weaker defences in place than Liberia where, alongside Sierra Leone and Gu...inea, the current Ebola crisis has already claimed 9,000 lives, and provoked an extraordinary international response to help contain it.
more
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
Introduction
Chapter A.10
Master of Science in Pharmaceutical Management Dissertation
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
The Lancet Volume 397, ISSUE 10269, P129-170, January 09, 2021
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...lt to fully assess the need for and impact of eradication campaigns using these tools. Under the recommendation of the WHO Diagnostic Technical Advisory Group (DTAG) for Neglected Tropical Diseases(NTDs), a working group was assembled and tasked with agreeing on priority use cases for developing target product profiles (TPPs) for new diagnostics tools.
more